Post by
Lesalpes29 on Nov 29, 2022 9:08am
Oncolytics Biotech product
Can be used positively in many cancers indications in combination with orher products offered by a couple of BP. It's enough to see many of them interested to buy Onc, oncy out. Of course they could wait but if they want a good buyout price it's probably now. I really think that all members of management team are ready for an offer and move on. GL
Comment by
Tarbaby on Nov 29, 2022 10:05am
Yes this company would be a great target for many bigger medical entities. Watch the share price double or tripple when that happens....long and strong on ONC